Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.48 |
| ▸ | CA6 | P23280 | 5/20 | 0.48 |
| ▸ | CA7 | P43166 | 5/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA4 | P22748 | 4/20 | 0.48 |
| ▸ | CA5A | P35218 | 4/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.48 |
| ▸ | CASP2 | P42575 | 2/20 | 0.48 |
| ▸ | F13A1 | P00488 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | THPO | P40225 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14163240 | 0.98 | CA12 (0.50) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3158951 | 0.96 | CA12 (0.48) | CA12CA6CA7CA9CA14 | |
| SCHEMBL31139219 | 0.90 | CA12 (0.50) | CA12CA6CA7CA9CA14 | |
| SCHEMBL22345317 | 0.85 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| SCHEMBL8850832 | 0.85 | TSHR (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL433529 | 0.85 | CYP2C19 (0.36) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28111017 | 0.84 | HRH3 (0.39) | MEN1KMT2ACYP2C19TSHRALDH1A1 | |
| SCHEMBL19214781 | 0.83 | TSHR (0.46) | CA2CYP1A2MEN1KMT2ACYP2C19 | |
| SCHEMBL25989954 | 0.81 | TSHR (0.56) | CYP1A2CYP2C19TSHRALDH1A1TP53 | |
| SCHEMBL23924138 | 0.80 | CA12 (0.55) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6677451-B2 | POLYMER STABILIZERS; OXYGEN, HEAT, RADIATION RESISTANCES; DISCOLORATION INHIBITION; COATINGS; FIBERS; TAPES; FILMS; PAPERMAKING; HALS; FIREPROOFING; OXIDATION OF A 1-ALLYL-SUBSTITUTED STERICALLY HINDERED AMINE | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-01-13 | — | — | US | disclosed |
| US-20020094976-A1 | Preparation of sterically hindered amine ethers | ZEDDA ALESSANDRO (IT) | 2002-07-18 | — | — | US | disclosed |
| US-6420462-B1 | OXIDATION RESISTANCE, HEAT RESISTANT AND ACTINIC DEGRADATIONHETEROCYCLIC AMINE OXIDES | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-07-16 | — | — | US | disclosed |
| US-6117995-A | OXIDATION OF THE CORRESPONDING HETEROCYCLIC AMINE COMPOUND | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094976-A1 | Preparation of sterically hindered amine ethers | CBR1, CBR3, RER1 | CA12 1504/4885CA6 1436/4885CA7 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.